04.11.2014 • News

Lanxess Realignment Could See 1,200 Jobs Go

A realignment scheme initiated by new Lanxess CEO Matthias Zachert last spring could see the chemical producer's 16,900-strong workforce cut by 7%, a German newspaper has reported.

The company has declined to comment before it publishes third-quarter results on Nov. 6.

Citing company sources, the daily Rheinische Post said it had learned that 1,200 jobs were on the chopping block as the world's largest synthetic rubber manufacturer deals with a global oversupply situation. It added that Lanxess plans to offer workers voluntary redundancy packages and early retirement schemes but also will not rule out layoffs.

As part of the company's three-phase Let's Lanxess Again strategy to take hold from January 2015, the CEO said earlier that it was likely to close production facilities in reaction to weak demand for auto ties and Asian competition.

Analysts have calculated that cutbacks in this dimension could save €50-60 million in costs annually.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read